Sílvia Pineda

ORCID: 0000-0003-4017-1480
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bladder and Urothelial Cancer Treatments
  • Biomedical Research and Pathophysiology
  • Cancer Immunotherapy and Biomarkers
  • Renal Transplantation Outcomes and Treatments
  • Estrogen and related hormone effects
  • Neonatal Health and Biochemistry
  • T-cell and B-cell Immunology
  • Urinary and Genital Oncology Studies
  • Amino Acid Enzymes and Metabolism
  • Breast Cancer Treatment Studies
  • Immune Cell Function and Interaction
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Epigenetics and DNA Methylation
  • Genetic Associations and Epidemiology
  • Cytomegalovirus and herpesvirus research
  • RNA modifications and cancer
  • Organ Transplantation Techniques and Outcomes
  • Single-cell and spatial transcriptomics
  • Immunotherapy and Immune Responses
  • Pancreatic and Hepatic Oncology Research
  • Computational Drug Discovery Methods
  • Neonatal Respiratory Health Research
  • Cancer-related Molecular Pathways
  • Methemoglobinemia and Tumor Lysis Syndrome

University of California, San Francisco
2017-2025

Universidad Complutense de Madrid
2021-2025

IRCCS Humanitas Research Hospital
2025

Spanish National Cancer Research Centre
2014-2023

Centro de Investigación Biomédica en Red de Cáncer
2019-2023

University of San Francisco
2021

Centro Nacional de Epidemiología
2007-2019

University of Liège
2015-2017

Center for Research in Environmental Epidemiology
2015

Universitat Pompeu Fabra
2015

Purpose We recently reported that the mRNA-based, 21-gene Genomic Health recurrence score (GHI-RS) provided additional prognostic information regarding distant beyond obtained from classical clinicopathologic factors (age, nodal status, tumor size, grade, endocrine treatment) in women with early breast cancer, confirming earlier reports. The aim of this article is to determine how much contained standard immunohistochemical (IHC) markers. Patients and Methods primary cohort comprised 1,125...

10.1200/jco.2010.31.2835 article EN Journal of Clinical Oncology 2011-10-12

Gene amplification of CCND1 is observed in a subgroup breast cancers with poor prognosis, whereas overexpression the protein cyclin D1 has been linked to both worse and better clinical outcome. have also associated resistance treatment tamoxifen or even potentially detrimental effect tamoxifen.To clarify these challenging partly contrasting predictive prognostic links for we analysed large cohort postmenopausal cancer patients randomised receive either adjuvant anastrozole tamoxifen, as part...

10.1186/bcr3161 article EN cc-by Breast Cancer Research 2012-04-04

Omics data integration is becoming necessary to investigate the genomic mechanisms involved in complex diseases. During process, many challenges arise such as heterogeneity, smaller number of individuals comparison parameters, multicollinearity, and interpretation validation results due their complexity lack knowledge about biological processes. To overcome some these issues, innovative statistical approaches are being developed. In this work, we propose a permutation-based method...

10.1371/journal.pgen.1005689 article EN public-domain PLoS Genetics 2015-12-08

Transplant rejection is the critical clinical end-point limiting indefinite survival after histocompatibility antigen (HLA) mismatched organ transplantation. The predominant cause of late graft loss antibody-mediated (AMR), a process whereby injury to caused by donor-specific antibodies, which bind HLA and non-HLA (nHLA) antigens. AMR incompletely diagnosed as donor/recipient (D/R) matching only limited locus nHLA immunogenic antigens remain be identified. We have developed an integrative...

10.3389/fimmu.2017.01687 article EN cc-by Frontiers in Immunology 2017-12-04

Studying immune repertoire in the context of organ transplant provides important information on how adaptive immunity may contribute and modulate graft rejection. Here we characterize peripheral blood individuals before after kidney using B cell receptor sequencing a longitudinal clinical study. Individuals who develop rejection transplantation have more diverse transplant, suggesting predisposition for post-transplant risk. Additionally, over 2 years follow-up, patients demonstrate specific...

10.1038/s41467-019-09930-3 article EN cc-by Nature Communications 2019-04-23

Platinum-based neoadjuvant chemotherapy (NAC) increases the survival of patients with organ-confined urothelial bladder cancer (UBC). In retrospective studies, basal/squamous (BASQ)-like tumors present more advanced disease and have worse prognosis. Transcriptomics-defined tumor subtypes are associated response to NAC.

10.3390/cancers12071784 article EN Cancers 2020-07-03

Abstract Background. A number of studies have provided widely heterogeneous results for and against the hypothesis that genetic variants in drug metabolizing enzymes can influence patient response to tamoxifen. Most these are confounded by relatively small numbers patients, lack comprehensive genotype information, detailed clinical outcome data, selection biases. The ATAC trial was a prospective randomized double-blind placebo-controlled designed compare adjuvant use anastrozole versus...

10.1158/0008-5472.sabcs10-s1-7 article EN Cancer Research 2010-12-01

Tumor-infiltrating B cells can play an important role in anti-tumor responses but their presence is not well understood. In this study, we extracted the cell receptor repertoires from 9522 tumor and adjacent non-tumor samples across 28 types Cancer Genome Atlas project performed diversity network analysis. We identified differences statistics subtypes observed a trend towards increased clonality primary tumors compared to tissues. also found significant associations between repertoire...

10.3389/fimmu.2021.790119 article EN cc-by Frontiers in Immunology 2022-01-05

Abstract Background Ulcerative Colitis (UC) is an heterogenous debilitating disease without a cure. The step-up therapy approach aims at controlling and alleviating intestinal inflammation by achieving maintaining clinical endoscopic remission. However, the rate of primary non-response or loss response to therapies still high. Predictive markers that accurately guide decisions about best therapeutic choice are unmet need. This study determine metabolic profiles UC patients explore...

10.1093/ecco-jcc/jjae190.0739 article EN Journal of Crohn s and Colitis 2025-01-01

Understanding the unique susceptibility of human kidney to pH dysfunction and injury in cystinosis is paramount developing new therapies preserve renal function. Renal proximal tubular epithelial cells (RPTECs) fibroblasts isolated from patients with were transcriptionally profiled. Lysosomal fractionation, immunoblotting, confocal microscopy, intracellular pH, TEM, mitochondrial stress test, membrane integrity assays performed for validation. CRISPR, CTNS -/- RPTECs generated. Alterations...

10.7554/elife.94169.2 preprint EN 2025-01-31

Understanding the unique susceptibility of human kidney to pH dysfunction and injury in cystinosis is paramount developing new therapies preserve renal function. Renal proximal tubular epithelial cells (RPTECs) fibroblasts isolated from patients with were transcriptionally profiled. Lysosomal fractionation, immunoblotting, confocal microscopy, intracellular pH, TEM, mitochondrial stress test performed for validation. CRISPR, CTNS -/- RPTECs generated. Alterations cell stress, autophagic...

10.7554/elife.94169.3 article EN cc-by eLife 2025-03-20

Background Infiltrating B and T cells have been observed in several tumor tissues, including pancreatic ductal adenocarcinoma (PDAC). The majority known PDAC risk factors point to a chronic inflammatory process leading different forms of immunological infiltration. Understanding infiltration may lead improved knowledge this devastating disease. Methods We extracted the immunoglobulins (IGs) cell receptors (TCRs) from RNA-sequencing 144 TCGA 180 normal tissue GTEx. used Shannon entropy find...

10.3389/fimmu.2021.730746 article EN cc-by Frontiers in Immunology 2021-09-23

SUMMARY An outbreak of Legionnaire's disease was detected in Pamplona, Spain, on 1 June 2006. Patients with pneumonia were tested to detect Legionella pneumophila antigen urine (Binax Now; Binax Inc., Scarborough, ME, USA), and all 146 confirmed cases interviewed. The related district 2 (22 012 inhabitants), where 45% the lived 50% had visited; 5% neighbouring districts. highest incidence found resident population (3/1000 section (14/1000). All 31 cooling towers analysed. L. Now) four...

10.1017/s0950268807009077 article EN Epidemiology and Infection 2007-07-30

Peripheral blood (PB) molecular patterns characterizing the different effector immune pathways driving distinct kidney rejection types remain to be fully elucidated. We hypothesized that transcriptome analysis using RNA sequencing (RNAseq) in samples of transplant patients would enable identification unique protein-coding and noncoding genes may able segregate phenotypes.We evaluated 37 biopsy-paired PB from discovery cohort, with stable (STA), antibody-mediated (AMR), T cell-mediated (TCMR)...

10.1016/j.ekir.2020.07.023 article EN cc-by-nc-nd Kidney International Reports 2020-07-26

Introduction Muscle-invasive bladder cancer (MIBC) is a heterogeneous disease with several taxonomic molecular subtypes showing different genetic, clinical, and epidemiological profiles. It has been suggested that MIBC-subtypes follow tumorigenesis pathways playing decisive roles at stages of tumor development, resulting in distinct microenvironment containing both innate adaptive immune cells (T B lymphocytes). We aim to characterize the MIBC by analyzing tumor-infiltrating T cell...

10.3389/fimmu.2023.986598 article EN cc-by Frontiers in Immunology 2023-02-03

Objectives: Different types of ‘-omics' data are becoming available in the post-genome era; still a single -omics assessment provides limited insights to understand biological mechanism complex diseases. Genomics, epigenomics and transcriptomics provide insight into molecular dysregulation neoplastic diseases, among them urothelial bladder cancer (UBC). Here, we propose detailed analytical framework necessary achieve an adequate integration three sets ultimately identify previously hidden...

10.1159/000381184 article EN Human Heredity 2015-01-01

Primary and secondary prevention can highly benefit a personalized medicine approach through the accurate discrimination of individuals at high risk developing specific disease from those moderate low risk. To this end precise prediction models need to be built. This endeavor requires characterization individual exposome, genome, phenome. Massive molecular omics data representing different layers biological processes host nonhost will enable build more models. Epidemiologists aim integrate...

10.1002/gepi.21992 article EN Genetic Epidemiology 2016-07-18
Divyansh Agarwal Sílvia Pineda Kyriaki Michailidou Jesús Herránz Guillermo Pita and 95 more Leticia T. Moreno M. Rosario Alonso Joe Dennis Qin Wang Manjeet K. Bolla Kerstin B. Meyer Primitiva Menéndez‐Rodríguez David Hardisson Marta Mendiola Anna González‐Neira Annika Lindblom Sara Margolin Anthony J. Swerdlow Alan Ashworth Nick Orr Michael E. Jones Keitaro Matsuo Hidemi Ito Hiroji Iwata Naoto Kondo Mikael Hartman Hui Miao Wei Yen Lim P T-C Iau Emma Sawyer Ian Tomlinson Michael J. Kerin Nicola Miller Daehee Kang J-Y Choi S K Park D‐Y Noh JL Hopper Daniel F. Schmidt Enes Makalic Melissa C. Southey Soo‐Hwang Teo Cheng Har Yip Kavitta Sivanandan W-T Tay Hiltrud Brauch T Brüning Ute Hamann Alison M. Dunning Mitul Shah Irene L. Andrulis Julia A. Knight Gord Glendon Sandrine Tchatchou Marjanka K. Schmidt Annegien Broeks Efraim H. Rosenberg Laura J. vanʼt Veer Peter A. Fasching Stefan P. Renner Arif B. Ekici Matthias W. Beckmann Chen‐Yang Shen C-N Hsiung JC Yu MF Hou William J. Blot Qiuyin Cai Anna H. Wu Tseng Cc David Van Den Berg Daniel O. Stram Angela Cox Ian W. Brock Malcolm Reed Kenneth Muir A. Lophatananon Sarah Stewart‐Brown Pornthep Siriwanarangsan Wei Zheng Sandra Deming-Halverson Martha J. Shrubsole Jirong Long X-O Shu Wei Lu Gao Yt B Zhang Paolo Radice Paolo Peterlongo Siranoush Manoukian Frédérique Mariette S Sangrajrang James McKay Fergus J. Couch Amanda E. Toland Drakoulis Yannoukakos Olivia Fletcher Nichola Johnson I dos Santos Silva Julian Peto

Breast cancer is one of the most common malignancies in women. Genome-wide association studies have identified FGFR2 as a breast susceptibility gene. Common variation other fibroblast growth factor (FGF) receptors might also modify risk. We tested this hypothesis by studying genotyped single-nucleotide polymorphisms (SNPs) and imputed SNPs FGFR1, FGFR3, FGFR4 FGFRL1 Cancer Association Consortium. Data were combined from 49 studies, including 53 835 cases 50 156 controls, which 89 050 (46 450...

10.1038/bjc.2013.769 article EN cc-by-nc-sa British Journal of Cancer 2014-02-01

Introduction Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway cancer genetic susceptibility. However, other related genes, rs1042522 (Arg72Pro), still present controversial results. We carried out an depth assessment associations between common germline and risk. Material Methods investigated 184 tagSNPs from 18 genes 1,058 cases 1,138 controls Spanish Bladder Cancer/EPICURO Study. Cases were...

10.1371/journal.pone.0089952 article EN cc-by PLoS ONE 2014-05-12
Coming Soon ...